✦ LIBER ✦

201 Multicenter Randomized Trial of Everolimus vs. Mycophenolate Mofetil in Heart Transplantation: Final 24 Month Analysis of Efficacy and Safety

✍ Scribed by J. Kobashigawa; D. Pauly; A. Kfoury; H. Ross; S.-S. Wang; B. Cantin; A. van Bakel; R.C. Starling; S. Hirt; G. Dong; C. Panis; P. Lopez; H. Eisen

Book ID: 116523858
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 125 KB
Volume: 31
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2012.01.200

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

North American Results from the Multicen

North American Results from the Multicenter Randomized Trial of Everolimus vs Mycophenolate Mofetil in Heart Transplantation

✍ Kobashigawa, J.; Pauly, D.; Ross, H.; Kfoury, A.; Van Bakel, A.; Patel, D.; Wila 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 92 KB

103Safety, efficacy and pharmacokinetics

103Safety, efficacy and pharmacokinetics of mycophenolate mofetil in liver transplantation: results of a multicenter, randomized, double blind trial

✍ KLINTMALM, G 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

24-month safety results of a randomized,

24-month safety results of a randomized, multicenter, double-blind study of Everolimus vs azathioprine in de novo heart transplant recipients

✍ H Eisen; J Kobashigawa; R.C Starling; N Cretin; J.S Jaffe; J Murphy 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Similar Efficacy and Safety of Enteric-c

✍ Jon A. Kobashigawa; Dale G. Renlund; Gino Gerosa; Luis Almenar; Howard J. Eisen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Six month data of a 12-month, single-bli

Six month data of a 12-month, single-blind, randomized, parallel group, multicenter study to investigate the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients

✍ J.A Kobashigawa; S.F Davis; D.G Renlund; M Hummel; G Gerosa; R Brambilla 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Efficacy and safety of de novo or early

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial

✍ Jacques Dantal; François Berthoux; Marie-Christine Moal; Lionel Rostaing; Christ 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB